Spravato, an FDA-approved nasal spray containing esketamine, has demonstrated remarkable efficacy in alleviating symptoms of severe depression, including those resistant to traditional antidepressants. The treatment, administered under the supervision of qualified medical professionals, offers rapid relief and a potential lifeline for individuals navigating the challenges of persistent depressive disorders.
